Back

Stroke and bleeding in low, intermediate and high risk patients with atrial fibrillation treated with edoxaban: Results of the ETNA-AF Europe registry

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation and oral anticoagulation 2 Oral Anticoagulation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Joris R De Groot

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

9 More presentations in this session

Presentation thumbnail
Mr P. Daniele (Vancouver, CA)
Abstract Slides
Presentation thumbnail
Doctor C. Binding (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Associate Professor H. Yu (Seoul, KR)
Abstract
Presentation thumbnail
Doctor A. Ruigomez (Madrid, ES)
Abstract
Presentation thumbnail
Doctor T. Nakano (Hiroshima, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Atrial fibrillation and oral anticoagulation 2

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Presentation
State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources